APO RESEARCH · REPORT
Biologic and Medical Imaging Reagents
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Product & engineering
Understand the product.
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
Selected research
Industry Research
Biologic and Medical Imaging Reagents Industry Research Report 2026
Market perspective
Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.
The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).
The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.
Read the full market overview
In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.
On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.
Report Scope
This report quantifies the global Biologic and Medical Imaging Reagents market in terms of revenue (US$ million) and, where applicable, service volume (Kiloton), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Kiloton) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biologic and Medical Imaging Reagents.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biologic and Medical Imaging Reagents Market by Company
Cardinal Health
Bracco
Bayer HealthCare
Curium Pharma
Hengrui Medicine
GE Healthcare
Lantheus Medical Imaging
Novartis (AAA)
Thermo Fisher Scientific
Jubilant DraxImage
PerkinElmer
Guerbet
Nihon Medi-Physics
YRPG
Biologic and Medical Imaging Reagents Segment by Type
Nuclear Imaging (PET & SPECT) Reagents
Magnetic Resonance Imaging (MRI) Reagents
Fluorescence Imaging Reagents
Ultrasound and X-ray Contrast Reagents
Other
Biologic and Medical Imaging Reagents Segment by Application
Hospitals
Clinics
Other
Biologic and Medical Imaging Reagents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic and Medical Imaging Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologic and Medical Imaging Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic and Medical Imaging Reagents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biologic and Medical Imaging Reagents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nuclear Imaging (PET & SPECT) Reagents
- Magnetic Resonance Imaging (MRI) Reagents
- Fluorescence Imaging Reagents
- Ultrasound and X-ray Contrast Reagents
- Other
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Cardinal Health
- Bracco
- Bayer HealthCare
- Curium Pharma
- Hengrui Medicine
- GE Healthcare
- Lantheus Medical Imaging
- Novartis (AAA)
- Thermo Fisher Scientific
- Jubilant DraxImage
- PerkinElmer
- Guerbet
- Nihon Medi-Physics
- YRPG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biologic and Medical Imaging Reagents by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Nuclear Imaging (PET & SPECT) Reagents
- 2.2.3 Magnetic Resonance Imaging (MRI) Reagents
- 2.2.4 Fluorescence Imaging Reagents
- 2.2.5 Ultrasound and X-ray Contrast Reagents
- 2.2.6 Other
- 2.3 Biologic and Medical Imaging Reagents by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Biologic and Medical Imaging Reagents Breakdown Data by Type
- 3.1 Global Biologic and Medical Imaging Reagents Historic Market Size by Type (2021-2026)
- 3.2 Global Biologic and Medical Imaging Reagents Forecasted Market Size by Type (2027-2032)
4 Biologic and Medical Imaging Reagents Breakdown Data by Application
- 4.1 Global Biologic and Medical Imaging Reagents Historic Market Size by Application (2021-2026)
- 4.2 Global Biologic and Medical Imaging Reagents Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biologic and Medical Imaging Reagents Market Perspective (2021-2032)
- 5.2 Global Biologic and Medical Imaging Reagents Growth Trends by Region
- 5.2.1 Global Biologic and Medical Imaging Reagents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biologic and Medical Imaging Reagents Historic Market Size by Region (2021-2026)
- 5.2.3 Biologic and Medical Imaging Reagents Forecasted Market Size by Region (2027-2032)
- 5.3 Biologic and Medical Imaging Reagents Market Dynamics
- 5.3.1 Biologic and Medical Imaging Reagents Industry Trends
- 5.3.2 Biologic and Medical Imaging Reagents Market Drivers
- 5.3.3 Biologic and Medical Imaging Reagents Market Challenges
- 5.3.4 Biologic and Medical Imaging Reagents Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biologic and Medical Imaging Reagents Players by Revenue
- 6.1.1 Global Top Biologic and Medical Imaging Reagents Players by Revenue (2021-2026)
- 6.1.2 Global Biologic and Medical Imaging Reagents Revenue Market Share by Players (2021-2026)
- 6.2 Global Biologic and Medical Imaging Reagents Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biologic and Medical Imaging Reagents Head Office and Area Served
- 6.4 Global Biologic and Medical Imaging Reagents Players, Product Type & Application
- 6.5 Global Biologic and Medical Imaging Reagents Manufacturers Established Date
- 6.6 Global Biologic and Medical Imaging Reagents Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biologic and Medical Imaging Reagents Market Size (2021-2032)
- 7.2 North America Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biologic and Medical Imaging Reagents Market Size by Country (2021-2026)
- 7.4 North America Biologic and Medical Imaging Reagents Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biologic and Medical Imaging Reagents Market Size (2021-2032)
- 8.2 Europe Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biologic and Medical Imaging Reagents Market Size by Country (2021-2026)
- 8.4 Europe Biologic and Medical Imaging Reagents Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biologic and Medical Imaging Reagents Market Size (2021-2032)
- 9.2 Asia-Pacific Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biologic and Medical Imaging Reagents Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biologic and Medical Imaging Reagents Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biologic and Medical Imaging Reagents Market Size (2021-2032)
- 10.2 South America Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biologic and Medical Imaging Reagents Market Size by Country (2021-2026)
- 10.4 South America Biologic and Medical Imaging Reagents Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biologic and Medical Imaging Reagents Market Size (2021-2032)
- 11.2 Middle East & Africa Biologic and Medical Imaging Reagents Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biologic and Medical Imaging Reagents Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biologic and Medical Imaging Reagents Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cardinal Health
- 12.1.1 Cardinal Health Company Information
- 12.1.2 Cardinal Health Business Overview
- 12.1.3 Cardinal Health Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.1.4 Cardinal Health Biologic and Medical Imaging Reagents Product Portfolio
- 12.1.5 Cardinal Health Recent Developments
- 12.2 Bracco
- 12.2.1 Bracco Company Information
- 12.2.2 Bracco Business Overview
- 12.2.3 Bracco Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.2.4 Bracco Biologic and Medical Imaging Reagents Product Portfolio
- 12.2.5 Bracco Recent Developments
- 12.3 Bayer HealthCare
- 12.3.1 Bayer HealthCare Company Information
- 12.3.2 Bayer HealthCare Business Overview
- 12.3.3 Bayer HealthCare Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.3.4 Bayer HealthCare Biologic and Medical Imaging Reagents Product Portfolio
- 12.3.5 Bayer HealthCare Recent Developments
- 12.4 Curium Pharma
- 12.4.1 Curium Pharma Company Information
- 12.4.2 Curium Pharma Business Overview
- 12.4.3 Curium Pharma Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.4.4 Curium Pharma Biologic and Medical Imaging Reagents Product Portfolio
- 12.4.5 Curium Pharma Recent Developments
- 12.5 Hengrui Medicine
- 12.5.1 Hengrui Medicine Company Information
- 12.5.2 Hengrui Medicine Business Overview
- 12.5.3 Hengrui Medicine Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.5.4 Hengrui Medicine Biologic and Medical Imaging Reagents Product Portfolio
- 12.5.5 Hengrui Medicine Recent Developments
- 12.6 GE Healthcare
- 12.6.1 GE Healthcare Company Information
- 12.6.2 GE Healthcare Business Overview
- 12.6.3 GE Healthcare Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.6.4 GE Healthcare Biologic and Medical Imaging Reagents Product Portfolio
- 12.6.5 GE Healthcare Recent Developments
- 12.7 Lantheus Medical Imaging
- 12.7.1 Lantheus Medical Imaging Company Information
- 12.7.2 Lantheus Medical Imaging Business Overview
- 12.7.3 Lantheus Medical Imaging Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.7.4 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Product Portfolio
- 12.7.5 Lantheus Medical Imaging Recent Developments
- 12.8 Novartis (AAA)
- 12.8.1 Novartis (AAA) Company Information
- 12.8.2 Novartis (AAA) Business Overview
- 12.8.3 Novartis (AAA) Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.8.4 Novartis (AAA) Biologic and Medical Imaging Reagents Product Portfolio
- 12.8.5 Novartis (AAA) Recent Developments
- 12.9 Thermo Fisher Scientific
- 12.9.1 Thermo Fisher Scientific Company Information
- 12.9.2 Thermo Fisher Scientific Business Overview
- 12.9.3 Thermo Fisher Scientific Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.9.4 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Product Portfolio
- 12.9.5 Thermo Fisher Scientific Recent Developments
- 12.10 Jubilant DraxImage
- 12.10.1 Jubilant DraxImage Company Information
- 12.10.2 Jubilant DraxImage Business Overview
- 12.10.3 Jubilant DraxImage Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.10.4 Jubilant DraxImage Biologic and Medical Imaging Reagents Product Portfolio
- 12.10.5 Jubilant DraxImage Recent Developments
- 12.11 PerkinElmer
- 12.11.1 PerkinElmer Company Information
- 12.11.2 PerkinElmer Business Overview
- 12.11.3 PerkinElmer Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.11.4 PerkinElmer Biologic and Medical Imaging Reagents Product Portfolio
- 12.11.5 PerkinElmer Recent Developments
- 12.12 Guerbet
- 12.12.1 Guerbet Company Information
- 12.12.2 Guerbet Business Overview
- 12.12.3 Guerbet Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.12.4 Guerbet Biologic and Medical Imaging Reagents Product Portfolio
- 12.12.5 Guerbet Recent Developments
- 12.13 Nihon Medi-Physics
- 12.13.1 Nihon Medi-Physics Company Information
- 12.13.2 Nihon Medi-Physics Business Overview
- 12.13.3 Nihon Medi-Physics Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.13.4 Nihon Medi-Physics Biologic and Medical Imaging Reagents Product Portfolio
- 12.13.5 Nihon Medi-Physics Recent Developments
- 12.14 YRPG
- 12.14.1 YRPG Company Information
- 12.14.2 YRPG Business Overview
- 12.14.3 YRPG Revenue in Biologic and Medical Imaging Reagents Business (2021-2026)
- 12.14.4 YRPG Biologic and Medical Imaging Reagents Product Portfolio
- 12.14.5 YRPG Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst